Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Wednesday, September 3, 2014

Time To Be Bullish On Novartis

The drug developed by Novartis which reduced cardiovascular deaths by 20%improved Novartis's chance to add a multi-billion dollar product to its pipeline.

http://ift.tt/Yb4hEF

No comments:

Post a Comment

Popular Stem Cell Roundup Posts